S02 ALLER-TOTAL
NDC 63479-1902, APIS MELLIFICA, BERBERIS VULGARIS, BOS TAURUS SKIN, CANIS FAMILIARIS SKIN, CAPRA HIRCUS HAIR, CHELIDONIUM MAJUS, EQUUS CABALLUS SKIN, FAGUS SYLVESTRIS, FELIS CATUS HAIR, FORMICUM ACIDUM, HISTAMINUM, HOUSE DUST, JUNIPERUS COMMUNIS, LAC VACCINUM, LUFFA OPERCULATA, MONOSODIUM GLUTAMATE, OVIS ARIES SKIN, PEANUTS, POLLEN MIX, RIBES NIGRUM, SABADILLA, SHEEP HAIR, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, URTICA URENS, WHEAT, solution/ drops, from Apex Energetics Inc..
- Product NDC
- 63479-1902
- Status
- Listed
- Labeler
- Apex Energetics Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1902 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EQUUS CABALLUS SKIN200 [hp_X]/mL
- FORMIC ACID200 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE200 [hp_X]/mL
- COW MILK200 [hp_X]/mL
- LUFFA OPERCULATA FRUIT6 [hp_X]/mL
- PEANUT30 [hp_X]/mL
- SCHOENOCAULON OFFICINALE SEED200 [hp_X]/mL
- SHEEP WOOL200 [hp_X]/mL
- SORGHUM HALEPENSE POLLEN200 [hp_X]/mL
- TARAXACUM OFFICINALE2 [hp_X]/mL
- WHEAT200 [hp_X]/mL
- XANTHIUM STRUMARIUM POLLEN200 [hp_X]/mL
- AMBROSIA ACANTHICARPA POLLEN200 [hp_X]/mL
- CHENOPODIUM ALBUM POLLEN200 [hp_X]/mL
- AMARANTHUS RETROFLEXUS POLLEN200 [hp_X]/mL
- CYNODON DACTYLON POLLEN200 [hp_X]/mL
- FAGUS SYLVATICA FLOWER BUD2 [hp_X]/mL
- FELIS CATUS HAIR200 [hp_X]/mL
- JUNIPERUS COMMUNIS STEM2 [hp_X]/mL
- APIS MELLIFERA4 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK1 [hp_X]/mL
- RIBES NIGRUM FLOWER BUD2 [hp_X]/mL
- CHELIDONIUM MAJUS1 [hp_X]/mL
- HOUSE DUST200 [hp_X]/mL
- MONOSODIUM GLUTAMATE90 [hp_X]/mL
- OVIS ARIES SKIN200 [hp_X]/mL
- SOLIDAGO VIRGAUREA FLOWERING TOP1 [hp_X]/mL
- URTICA URENS2 [hp_X]/mL
- AMBROSIA ARTEMISIIFOLIA POLLEN200 [hp_X]/mL
- AMBROSIA PSILOSTACHYA POLLEN200 [hp_X]/mL
- AMBROSIA TRIFIDA POLLEN200 [hp_X]/mL
- ANTHOXANTHUM ODORATUM POLLEN200 [hp_X]/mL
- BOS TAURUS SKIN200 [hp_X]/mL
- CANIS LUPUS FAMILIARIS SKIN200 [hp_X]/mL
- CAPRA HIRCUS HAIR200 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Animal Fur [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Dander [CS]; Dietary Proteins [CS]; Dietary Proteins [CS]; Dietary Proteins [CS]; Grain Proteins [EXT]; House Dust [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Milk Proteins [CS]; Non-Standardized Animal Hair Allergenic Extract [EPC]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized House Dust Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Nut Proteins [EXT]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Salivary Proteins and Peptides [CS]; Standardized Animal Hair Allergenic Extract [EPC]; Standardized Insect Venom Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63479-1902-1 | 63479190201 | 30 mL in 1 BOTTLE, GLASS (63479-1902-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63479-1902 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1902 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63479-1902. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.